Modeling and simulation as a tool to bridge efficacy and safety data in special populations.

Harnisch, L; Shepard, T; Pons, G; Della Pasqua, O

Harnisch, L; Shepard, T; Pons, G; Della Pasqua, O.

Affiliation

Harnisch L; Pfizer, Pharmacometrics, Global Clinical Pharmacology, Sandwich, UK.

CPT Pharmacometrics Syst Pharmacol ; 2: e28, 2013 Feb 27.

Article in En | MEDLINE | ID: mdl-23835939

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600759
https://dx.doi.org/10.1038/psp.2013.6

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2013 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600759
https://dx.doi.org/10.1038/psp.2013.6

XML

PubMed Links

Search on Google